LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,152.22
−0.02%Forward multiples
Based on analyst estimates
- P/E forward
- 28.19x
- P/E 2026E
- 31.33x
- P/E 2027E
- 24.43x
- P/E 2028E
- 21.28x
- P/S forward
- 11.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.55x
- PEG TTM
- 1.04x
- Price / book
- 32.02x
- Price / sales
- 13.62x
- Price / cash flow
- 38.62x
Enterprise value
- Enterprise value
- $1.13T
- EV / sales
- 14.19x
- EV / EBITDA
- 26.11x
- EV / EBIT
- 28.54x
- Market cap
- $1.08T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026